1. Home
  2. CPRX vs WB Comparison

CPRX vs WB Comparison

Compare CPRX & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

N/A

Current Price

$24.76

Market Cap

3.0B

Sector

Health Care

ML Signal

N/A

Logo Weibo Corporation

WB

Weibo Corporation

N/A

Current Price

$9.86

Market Cap

2.5B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CPRX
WB
Founded
2002
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
CPRX
WB
Price
$24.76
$9.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$35.00
$14.00
AVG Volume (30 Days)
1.2M
885.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
17.19%
EPS Growth
28.24
N/A
EPS
1.68
N/A
Revenue
$119,072,803.00
N/A
Revenue This Year
$8.00
$0.53
Revenue Next Year
$9.77
$2.15
P/E Ratio
$14.38
$5.66
Revenue Growth
16.39
N/A
52 Week Low
$19.05
$7.10
52 Week High
$26.56
$12.96

Technical Indicators

Market Signals
Indicator
CPRX
WB
Relative Strength Index (RSI) 54.90 43.99
Support Level $22.25 $9.81
Resistance Level $24.86 $10.51
Average True Range (ATR) 0.98 0.25
MACD 0.03 -0.02
Stochastic Oscillator 78.80 44.53

Price Performance

Historical Comparison
CPRX
WB

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

About WB Weibo Corporation

Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.

Share on Social Networks: